Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021

The safety profile of the 9-valent human papillomavirus vaccine (9vHPV) was evaluated based on the reporting rate of adverse events following immunization (AEFI) obtained from the passive surveillance data in Zhejiang. The 9vHPV AEFI reports in Zhejiang were collected and reviewed from the National...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human vaccines & immunotherapeutics 2022-12, Vol.18 (7), p.2152256
Hauptverfasser:	Chen, Fuxing, Pan, Xuejiao, Liang, Hui, Shen, Lingzhi, Wang, Ying, Chen, Yaping, Lv, Huakun, Hu, Yu
Format:	Artikel
Sprache:	eng
Schlagworte:	9-valent human papillomavirus vaccine Adverse Drug Reaction Reporting Systems AEFI (adverse events following immunization) China HPV Human Papillomavirus Viruses Humans Immunization - adverse effects Infant Papillomavirus Vaccines - adverse effects post-licensure surveillance safety Syncope - chemically induced Urticaria - chemically induced vaccination Vaccination - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!